Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Comparative effectiveness of medical treatments [[electronic resource] /] / Meter [i.e. Peter] Villa and Sophia Brun, editors
| Comparative effectiveness of medical treatments [[electronic resource] /] / Meter [i.e. Peter] Villa and Sophia Brun, editors |
| Pubbl/distr/stampa | New York, : Nova Science Publishers, Inc., c2009 |
| Descrizione fisica | 1 online resource (106 p.) |
| Disciplina | 615.1 |
| Altri autori (Persone) |
VillaPeter
BrunSophia |
| Collana |
Health care issues, costs and access series
Novinka |
| Soggetto topico |
Drugs - Effectiveness
Therapeutics Therapeutics - Costs |
| Soggetto genere / forma | Electronic books. |
| ISBN | 1-61728-193-X |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910458209203321 |
| New York, : Nova Science Publishers, Inc., c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Comparative effectiveness of medical treatments [[electronic resource] /] / Meter [i.e. Peter] Villa and Sophia Brun, editors
| Comparative effectiveness of medical treatments [[electronic resource] /] / Meter [i.e. Peter] Villa and Sophia Brun, editors |
| Pubbl/distr/stampa | New York, : Nova Science Publishers, Inc., c2009 |
| Descrizione fisica | 1 online resource (106 p.) |
| Disciplina | 615.1 |
| Altri autori (Persone) |
VillaPeter
BrunSophia |
| Collana |
Health care issues, costs and access series
Novinka |
| Soggetto topico |
Drugs - Effectiveness
Therapeutics Therapeutics - Costs |
| ISBN | 1-61728-193-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910791484603321 |
| New York, : Nova Science Publishers, Inc., c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Comparative effectiveness of medical treatments / / Meter [i.e. Peter] Villa and Sophia Brun, editors
| Comparative effectiveness of medical treatments / / Meter [i.e. Peter] Villa and Sophia Brun, editors |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | New York, : Nova Science Publishers, Inc., c2009 |
| Descrizione fisica | 1 online resource (106 p.) |
| Disciplina | 615.1 |
| Altri autori (Persone) |
VillaPeter
BrunSophia |
| Collana |
Health care issues, costs and access series
Novinka |
| Soggetto topico |
Drugs - Effectiveness
Therapeutics Therapeutics - Costs |
| ISBN | 1-61728-193-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- COMPARATIVE EFFECTIVENESS OF MEDICAL TREATMENTS -- COMPARATIVE EFFECTIVENESS OF MEDICAL TREATMENTS -- LIBRARY OF CONGRESS CATALOGING-IN-PUBLICATION DATA -- CONTENTS -- PREFACE -- Chapter 1: RESEARCH ON THE COMPARATIVE EFFECTIVENESS OF MEDICAL TREATMENTS: OPTIONS FOR AN EXPANDED FEDERAL ROLE BEFORE THE SUBCOMMITTEE ON HEALTH COMMITTEE ON WAYS AND MEANSU.S. HOUSE OF REPRESENTATIVES∗JUNE 12, 2007 -- BACKGROUND ON PAST AND CURRENT EFFORTS -- What Is Comparative Effectiveness? -- Research in the Private Sector -- Past and Current Federal Efforts to Assess Medical Treatments -- Comparative Effectiveness in Other Countries -- OPTIONS FOR ORGANIZING AND FUNDING FEDERAL RESEARCH EFFORTS -- ISSUES AND CHALLENGES IN COMPARING THE EFFECTIVENESS OF TREATMENTS -- Methods of Research -- Scope of Analysis and Dissemination of Results -- POTENTIAL IMPLICATIONS FOR HEALTH CARE SPENDING -- Potential for Savings on Health Care -- Possible Responses Under Private and Public Insurance Plans -- CONCLUSION -- REFERENCES -- Chapter 2: PRODUCING COMPARATIVE-EFFECTIVENESS INFORMATION -- CONTEXT FOR MEDICARE PAYMENT POLICY -- DEFINING COMPARATIVE EFFECTIVENESS -- The Private Sector Does Not Systematically Produce andDisseminate Objective Comparative-Effectiveness Information -- Conducting Comparative-Effectiveness Studies Is Not the PrimaryFocus of Any Federal Agency -- The United States Needs to Produce More Credible Comparative-Effectiveness Information -- Comparative Information Could Help Payers Make Better Policies -- More Comparative Information Could Help Support BetterDecision Making by Patients and Providers -- Functions and Activities of a Comparative-Effectiveness Entity -- Structuring an Entity to Examine and Report on ComparativeEffectiveness -- CONCLUSION.
Chapter 3: TESTIMONY OF STEVEN M. TEUTSCH, M.D., M.P.H. EXECUTIVE DIRECTOR, OUTCOMES RESEARCH, EXTERNAL MEDICAL AND SCIENTIFIC AFFAIRS,MERCK & -- CO., INC. BEFORE THE HOUSE WAYS AND MEANS, HEALTH SUBCOMMITTEE CONCERNING COMPARATIVE EFFECTIVENESS JUNE 12, 2007 -- MERCK AND COMPARATIVE EFFECTIVENESS -- NECESSARY CHARACTERISTICS OF THE NATIONAL COMPARATIVE EFFECTIVENESS EFFORT -- STAKEHOLDER CONCERNS -- CONCLUSION -- SELECTED PUBLICATIONS RELEVANT TO COMPARATIVE EFFECTIVENESS -- Chapter 4: HOUSE COMMITTEE ON WAYS AND MEANS, STATEMENT OF CAROLYN M. CLANCY, M.D., DIRECTOR,AGENCY FOR HEALTHCARE RESEARCH AND QUALITY, ROCKVILLE, MARYLAND TESTIMONY BEFORE THE SUBCOMMITTEE ON HEALTH OF THE HOUSE COMMITTEE ON WAYS AND MEANS JUNE 12, 2007 -- EFFECTIVE HEALTH CARE PROGRAM -- COMPARATIVE EFFECTIVENESS REVIEWS -- Gastroesophageal Reflux Disease (GERD) -- Breast Cancer Diagnosis -- Managing Anemia in Cancer Patients -- Osteoarthritis Drugs -- Renal Artery Stenosis -- Off-Label Use of Atypical Antipsychotics -- Second-Generation Antidepressants -- Health Information Technology -- CONCLUSION -- Chapter 5: HOUSE COMMITTEE ON WAYS AND MEANS, STATEMENT OF DAVID DALE, M.D.,PRESIDENT, AMERICAN COLLEGE OF PHYSICIANS TESTIMONY BEFORE THE SUBCOMMITTEE ON HEALTH OF THE HOUSE COMMITTEE ON WAYS AND MEANS JUNE 12, 2007 -- THE PUBLIC NEED FOR COMPARATIVE CLINICAL EFFECTIVENESS RESEARCH -- USE OF COMPARATIVE EFFECTIVENESS IN BENEFIT DESIGN DECISIONS -- COMPARATIVE CLINICAL EFFECTIVENESS RESEARCH AND SHARED DECISION-MAKING -- SUMMARY AND CONCLUSION -- REFERENCES -- Chapter 6: HOUSE COMMITTEE ON WAYS AND MEANS, STATEMENT OF GAIL SHEARER, DIRECTOR, HEALTH POLICY ANALYSIS, CONSUMERS UNION TESTIMONY BEFORE THE SUBCOMMITTEE ON HEALTH OF THE HOUSE COMMITTEE ON WAYS AND MEANS JUNE 12, 2007 -- REFERENCES. Chapter 7: HOUSE COMMITTEE ON WAYS AND MEANS, STATEMENT OF SUSAN HEARN, PH.D., SENIOR PROJECT MANAGER IN ENVIRONMENT HEALTH AND SAFETY, DOW CHEMICAL COMPANY, MIDLAND, MICHIGAN TESTIMONY BEFORE THE SUBCOMMITTEE ON HEALTH OF THE HOUSE COMMITTEE ON WAYS AND MEANS JUNE 12, 2007 -- Chapter 8: HOUSE COMMITTEE ON WAYS AND MEANS, STATEMENT OF THE HONORABLE THOMAS ALLEN, A REPRESENTATIVE IN CONGRESS FROM THE STATE OF MAINE TESTIMONY BEFORE THE SUBCOMMITTEE ON HEALTH OF THE HOUSE COMMITTEE ON WAYS AND MEANS JUNE 12, 2007 -- Chapter 9: BACKGROUND TO HEARING ON STRATEGIES TO INCREASE INFORMATION ON COMPARATIVE CLINICAL EFFECTIVENESS FROM HOUSE WAYS AND MEANS HEALTH SUBCOMMITTEE CHAIRMAN PETE STARK -- FOCUS OF THE HEARING -- INDEX. |
| Record Nr. | UNINA-9911102213703321 |
| New York, : Nova Science Publishers, Inc., c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Comparative effectiveness of medical treatments / / Meter [i.e. Peter] Villa and Sophia Brun, editors
| Comparative effectiveness of medical treatments / / Meter [i.e. Peter] Villa and Sophia Brun, editors |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | New York, : Nova Science Publishers, Inc., c2009 |
| Descrizione fisica | 1 online resource (106 p.) |
| Disciplina | 615.1 |
| Altri autori (Persone) |
VillaPeter
BrunSophia |
| Collana |
Health care issues, costs and access series
Novinka |
| Soggetto topico |
Drugs - Effectiveness
Therapeutics Therapeutics - Costs |
| ISBN | 1-61728-193-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- COMPARATIVE EFFECTIVENESS OF MEDICAL TREATMENTS -- COMPARATIVE EFFECTIVENESS OF MEDICAL TREATMENTS -- LIBRARY OF CONGRESS CATALOGING-IN-PUBLICATION DATA -- CONTENTS -- PREFACE -- Chapter 1: RESEARCH ON THE COMPARATIVE EFFECTIVENESS OF MEDICAL TREATMENTS: OPTIONS FOR AN EXPANDED FEDERAL ROLE BEFORE THE SUBCOMMITTEE ON HEALTH COMMITTEE ON WAYS AND MEANSU.S. HOUSE OF REPRESENTATIVES∗JUNE 12, 2007 -- BACKGROUND ON PAST AND CURRENT EFFORTS -- What Is Comparative Effectiveness? -- Research in the Private Sector -- Past and Current Federal Efforts to Assess Medical Treatments -- Comparative Effectiveness in Other Countries -- OPTIONS FOR ORGANIZING AND FUNDING FEDERAL RESEARCH EFFORTS -- ISSUES AND CHALLENGES IN COMPARING THE EFFECTIVENESS OF TREATMENTS -- Methods of Research -- Scope of Analysis and Dissemination of Results -- POTENTIAL IMPLICATIONS FOR HEALTH CARE SPENDING -- Potential for Savings on Health Care -- Possible Responses Under Private and Public Insurance Plans -- CONCLUSION -- REFERENCES -- Chapter 2: PRODUCING COMPARATIVE-EFFECTIVENESS INFORMATION -- CONTEXT FOR MEDICARE PAYMENT POLICY -- DEFINING COMPARATIVE EFFECTIVENESS -- The Private Sector Does Not Systematically Produce andDisseminate Objective Comparative-Effectiveness Information -- Conducting Comparative-Effectiveness Studies Is Not the PrimaryFocus of Any Federal Agency -- The United States Needs to Produce More Credible Comparative-Effectiveness Information -- Comparative Information Could Help Payers Make Better Policies -- More Comparative Information Could Help Support BetterDecision Making by Patients and Providers -- Functions and Activities of a Comparative-Effectiveness Entity -- Structuring an Entity to Examine and Report on ComparativeEffectiveness -- CONCLUSION.
Chapter 3: TESTIMONY OF STEVEN M. TEUTSCH, M.D., M.P.H. EXECUTIVE DIRECTOR, OUTCOMES RESEARCH, EXTERNAL MEDICAL AND SCIENTIFIC AFFAIRS,MERCK & -- CO., INC. BEFORE THE HOUSE WAYS AND MEANS, HEALTH SUBCOMMITTEE CONCERNING COMPARATIVE EFFECTIVENESS JUNE 12, 2007 -- MERCK AND COMPARATIVE EFFECTIVENESS -- NECESSARY CHARACTERISTICS OF THE NATIONAL COMPARATIVE EFFECTIVENESS EFFORT -- STAKEHOLDER CONCERNS -- CONCLUSION -- SELECTED PUBLICATIONS RELEVANT TO COMPARATIVE EFFECTIVENESS -- Chapter 4: HOUSE COMMITTEE ON WAYS AND MEANS, STATEMENT OF CAROLYN M. CLANCY, M.D., DIRECTOR,AGENCY FOR HEALTHCARE RESEARCH AND QUALITY, ROCKVILLE, MARYLAND TESTIMONY BEFORE THE SUBCOMMITTEE ON HEALTH OF THE HOUSE COMMITTEE ON WAYS AND MEANS JUNE 12, 2007 -- EFFECTIVE HEALTH CARE PROGRAM -- COMPARATIVE EFFECTIVENESS REVIEWS -- Gastroesophageal Reflux Disease (GERD) -- Breast Cancer Diagnosis -- Managing Anemia in Cancer Patients -- Osteoarthritis Drugs -- Renal Artery Stenosis -- Off-Label Use of Atypical Antipsychotics -- Second-Generation Antidepressants -- Health Information Technology -- CONCLUSION -- Chapter 5: HOUSE COMMITTEE ON WAYS AND MEANS, STATEMENT OF DAVID DALE, M.D.,PRESIDENT, AMERICAN COLLEGE OF PHYSICIANS TESTIMONY BEFORE THE SUBCOMMITTEE ON HEALTH OF THE HOUSE COMMITTEE ON WAYS AND MEANS JUNE 12, 2007 -- THE PUBLIC NEED FOR COMPARATIVE CLINICAL EFFECTIVENESS RESEARCH -- USE OF COMPARATIVE EFFECTIVENESS IN BENEFIT DESIGN DECISIONS -- COMPARATIVE CLINICAL EFFECTIVENESS RESEARCH AND SHARED DECISION-MAKING -- SUMMARY AND CONCLUSION -- REFERENCES -- Chapter 6: HOUSE COMMITTEE ON WAYS AND MEANS, STATEMENT OF GAIL SHEARER, DIRECTOR, HEALTH POLICY ANALYSIS, CONSUMERS UNION TESTIMONY BEFORE THE SUBCOMMITTEE ON HEALTH OF THE HOUSE COMMITTEE ON WAYS AND MEANS JUNE 12, 2007 -- REFERENCES. Chapter 7: HOUSE COMMITTEE ON WAYS AND MEANS, STATEMENT OF SUSAN HEARN, PH.D., SENIOR PROJECT MANAGER IN ENVIRONMENT HEALTH AND SAFETY, DOW CHEMICAL COMPANY, MIDLAND, MICHIGAN TESTIMONY BEFORE THE SUBCOMMITTEE ON HEALTH OF THE HOUSE COMMITTEE ON WAYS AND MEANS JUNE 12, 2007 -- Chapter 8: HOUSE COMMITTEE ON WAYS AND MEANS, STATEMENT OF THE HONORABLE THOMAS ALLEN, A REPRESENTATIVE IN CONGRESS FROM THE STATE OF MAINE TESTIMONY BEFORE THE SUBCOMMITTEE ON HEALTH OF THE HOUSE COMMITTEE ON WAYS AND MEANS JUNE 12, 2007 -- Chapter 9: BACKGROUND TO HEARING ON STRATEGIES TO INCREASE INFORMATION ON COMPARATIVE CLINICAL EFFECTIVENESS FROM HOUSE WAYS AND MEANS HEALTH SUBCOMMITTEE CHAIRMAN PETE STARK -- FOCUS OF THE HEARING -- INDEX. |
| Record Nr. | UNINA-9911134764703321 |
| New York, : Nova Science Publishers, Inc., c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||